These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9223277)

  • 21. Crystal structure of a catalytic antibody Fab with esterase-like activity.
    Golinelli-Pimpaneau B; Gigant B; Bizebard T; Navaza J; Saludjian P; Zemel R; Tawfik DS; Eshhar Z; Green BS; Knossow M
    Structure; 1994 Mar; 2(3):175-83. PubMed ID: 8069632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete reaction cycle of a cocaine catalytic antibody at atomic resolution.
    Zhu X; Dickerson TJ; Rogers CJ; Kaufmann GF; Mee JM; McKenzie KM; Janda KD; Wilson IA
    Structure; 2006 Feb; 14(2):205-16. PubMed ID: 16472740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct hydroxide attack is a plausible mechanism for amidase antibody 43C9.
    Chong LT; Bandyopadhyay P; Scanlan TS; Kuntz ID; Kollman PA
    J Comput Chem; 2003 Sep; 24(12):1371-7. PubMed ID: 12868101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
    Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution.
    Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA
    Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune versus natural selection: antibody aldolases with enzymic rates but broader scope.
    Barbas CF; Heine A; Zhong G; Hoffmann T; Gramatikova S; Björnestedt R; List B; Anderson J; Stura EA; Wilson IA; Lerner RA
    Science; 1997 Dec; 278(5346):2085-92. PubMed ID: 9405338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody.
    Zhang X; Deng Q; Yoo SH; Houk KN
    J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological origins of binding and catalysis in a Diels-Alderase antibody.
    Romesberg FE; Spiller B; Schultz PG; Stevens RC
    Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural origins of efficient proton abstraction from carbon by a catalytic antibody.
    Debler EW; Ito S; Seebeck FP; Heine A; Hilvert D; Wilson IA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):4984-9. PubMed ID: 15788533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The preparation and crystallization of Fab fragments of a family of mouse esterolytic catalytic antibodies and their complexes with a transition-state analogue.
    Muranova TA; Ruzheinikov SN; Sedelnikova SE; Moir A; Partridge LJ; Kakinuma H; Takahashi N; Shimazaki K; Sun J; Nishi Y; Rice DW
    Acta Crystallogr D Biol Crystallogr; 2001 Aug; 57(Pt 8):1192-5. PubMed ID: 11468416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational effects in biological catalysis: an antibody-catalyzed oxy-cope rearrangement.
    Mundorff EC; Hanson MA; Varvak A; Ulrich H; Schultz PG; Stevens RC
    Biochemistry; 2000 Feb; 39(4):627-32. PubMed ID: 10651626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
    Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
    J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing the Ser-Ser-Lys catalytic triad mechanism of peptide amidase: computational studies of the ground state, transition state, and intermediate.
    Valiña AL; Mazumder-Shivakumar D; Bruice TC
    Biochemistry; 2004 Dec; 43(50):15657-72. PubMed ID: 15595822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization of a carbamatase catalytic antibody Fab fragment and its complex with a transition-state analogue.
    Muranova TA; Ruzheinikov SN; Higginbottom A; Clipson JA; Blackburn GM; Wentworth P; Datta A; Rice DW; Partridge LJ
    Acta Crystallogr D Biol Crystallogr; 2004 Jan; 60(Pt 1):172-4. PubMed ID: 14684920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The thiolase reaction mechanism: the importance of Asn316 and His348 for stabilizing the enolate intermediate of the Claisen condensation.
    Meriläinen G; Poikela V; Kursula P; Wierenga RK
    Biochemistry; 2009 Nov; 48(46):11011-25. PubMed ID: 19842716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity.
    Gololobov GV; Rumbley CA; Rumbley JN; Schourov DV; Makarevich OI; Gabibov AG; Voss EW; Rodkey LS
    Mol Immunol; 1997 Oct; 34(15):1083-93. PubMed ID: 9519766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.